Overactive Bladder – Epidemiology – Emerging Markets Data
DRG Epidemiology’s coverage of overactive bladder (OAB) comprises epidemiological estimates of key patient populations in 14 mature and emerging pharmaceutical markets worldwide. We report the prevalence of OAB for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the other countries covered in this report.
DRG Epidemiology’s OAB forecast will answer the following question:
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of OAB over the forecast period?
All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is provided for full transparency into research and methods.
In addition to the total number of cases for each forecast year, DRG Epidemiology provides at least ten years of forecast data for the following OAB subpopulations:
- Total prevalent cases by subtype.
- Total prevalent cases by severity.
- Total prevalent cases by etiology.
Note: Coverage may vary by country.
Table of contents
- Overactive Bladder - Epidemiology - Emerging Markets Data
- Introduction
- Key Findings
- Key Updates
- Total Prevalence of Overactive Bladder per 1,000 People Aged 20+ in 2021 and 2031
- Relative Sizes of the Contributing Factors to the Trend in Total Prevalent Cases of Overactive Bladder Over the Next 10 Years
- Analysis of the Total Prevalent Cases of Overactive Bladder in 2021 by Severity
- Epidemiology Data
- Methods
- Total Prevalent Cases
- Total Prevalent Cases by Subtype
- Total Prevalent Cases by Severity
- Total Prevalent Cases by Etiology
- Reference Materials
- Literature Review
- Studies Included in the Analysis of Overactive Bladder
- Studies Excluded from the Analysis of Overactive Bladder
- Risk/Protective Factors
- Risk/Protective Factors for Overactive Bladder
- Bibliography
- Abbreviations
- Glossary
- Literature Review
- Introduction
Stephanie Niquita Phankon, M.B.B.S., M.P.H., is a Senior Epidemiologist at DRG, part of Clarivate. She trained as a community physician and has supervised and coordinated various governmental and nongovernmental public health projects. She holds an M.P.H. specializing in epidemiology from the Tata Institute of Social Sciences in Mumbai and a medical degree from Hubei University of Chinese Medicine in the People’s Republic of China.
